Everads Injector in Suprachoroidal Administration of TA Suspension, for Treatment of Patients With DME

Clinical trial NCT06314217 · COMPLETED

Trial details

NCT number: NCT06314217
Sponsor: Everads Therapy
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2024-02-18
Primary completion: 2025-03-26
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.